Lessons from 801 clinical TFE3/TFEB fluorescence in situ hybridization assays performed on renal cell carcinoma suspicious for MiTF family aberrations

Online journal article in Surgical Pathology that offers 1.0 continuing education (CME) credit that can be used to fulfill CC Part II requirements.

Quantity:

Want to save more?

Log into see if you qualify for a lower rate.

Members

save $5.00 or more

Intended Audience: Pathologists, Residents, Clinical Scientists, Pathologist Assistants

Upon completion of this activity, you will be able to:

List the defined types of microphthalmia-associated transcription family (MiTF) altered renal cell carcinomas (RCC) according to the 2022 World Health...

Intended Audience: Pathologists, Residents, Clinical Scientists, Pathologist Assistants

Upon completion of this activity, you will be able to:

List the defined types of microphthalmia-associated transcription family (MiTF) altered renal cell carcinomas (RCC) according to the 2022 World Health Organization (WHO) classification of genitourinary tumors.
Describe the currently recognized genetic alterations known to occur in MiTF-RCC.
Estimate the frequency of the various types of genetic alterations seen in MiTF-RCC and their association, if any, with patient age.

View More View Less